We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$527B
AUM Growth
-$50.5B
Cap. Flow
-$9.14B
Cap. Flow %
-1.73%
Top 10 Hldgs %
31.73%
Holding
16,069
New
1,671
Increased
6,327
Reduced
6,228
Closed
1,710

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.44B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.15B
3
GEHC icon
GE HealthCare
GEHC
+$552M
4
DHR icon
Danaher
DHR
+$447M
5
MSTR icon
Strategy Inc
MSTR
+$416M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$989M
2
BA icon
Boeing
BA
+$893M
3
BAC icon
Bank of America
BAC
+$753M
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$750M
5
KO icon
Coca-Cola
KO
+$638M

Sector Composition

Rank Sector Weight
1 Healthcare 3.24%
2 Technology 2.87%
3 Financials 2.43%
4 Consumer Discretionary 2.22%
5 Industrials 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRO icon
14301
PUT
Spero Therapeutics
SPRO
$71.2M
$72 ﹤0.01%
100
-100
-50% -$84
ORMP icon
14302
Oramed Pharmaceuticals
ORMP
$183M
$71 ﹤0.01%
33
-72,456
-100% -$167K
PEGA icon
14303
Pegasystems
PEGA
$5.22B
$70 ﹤0.01%
2
-422,166
-100% -$18.7M
EVTL icon
14304
CALL
Vertical Aerospace
EVTL
$176M
$67 ﹤0.01%
+20
New +$112
FRSX
14305
PUT
Foresight Autonomous Holdings
FRSX
$3.84M
$65 ﹤0.01%
+5
New +$103
CTMX icon
14306
CytomX Therapeutics
CTMX
$723M
$64 ﹤0.01%
100
-322,211
-100% -$250K
INCY icon
14307
Incyte
INCY
$24.4B
$61 ﹤0.01%
1
-229,868
-100% -$16M
TLPH icon
14308
PUT
Talphera
TLPH
$70.6M
$50 ﹤0.01%
+100
New +$61
LVLU icon
14309
PUT
Lulu's Fashion Lounge
LVLU
$53.7M
$40 ﹤0.01%
+7
New +$79
EQ icon
14310
PUT
Equillium
EQ
$143M
$39 ﹤0.01%
+100
New +$75
MCRB icon
14311
Seres Therapeutics
MCRB
$50.8M
$34 ﹤0.01%
2
– –
OVID icon
14312
PUT
Ovid Therapeutics
OVID
$474M
$31 ﹤0.01%
100
-100
-50% -$61
ACHC icon
14313
Acadia Healthcare
ACHC
$2.95B
$30 ﹤0.01%
1
-1,900,267
-100% -$72.4M
IPG
14314
DELISTED
Interpublic Group of Companies
IPG
$27 ﹤0.01%
1
-618,248
-100% -$17M
HTOO icon
14315
PUT
Fusion Fuel Green
HTOO
$18M
$26 ﹤0.01%
3
-431
-99% -$6.52K
PACB icon
14316
Pacific Biosciences
PACB
$447M
$26 ﹤0.01%
22
-360,959
-100% -$554K
PRLD icon
14317
Prelude Therapeutics
PRLD
$360M
$26 ﹤0.01%
34
-10,263
-100% -$9.57K
KG
14318
Kestrel Group
KG
$70.5M
$13 ﹤0.01%
1
-6,175
-100% -$116K
LVO icon
14319
LiveOne
LVO
$59.9M
$8 ﹤0.01%
+1
New +$10
WW
14320
DELISTED
WW International
WW
$4 ﹤0.01%
7
-170,604
-100% -$148K
AAXJ icon
14321
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
– –
-100
Closed -$7.22K
AAXJ icon
14322
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
– –
-4,500
Closed -$325K
ABEQ icon
14323
Absolute Select Value ETF
ABEQ
$145M
– –
-12,996
Closed -$409K
ABEV icon
14324
Ambev
ABEV
$47B
– –
-2,053,900
Closed -$4.11M
ABOS icon
14325
Acumen Pharmaceuticals
ABOS
$162M
– –
-9,597
Closed -$13.7K
571 572
573
574 575

Similar funds

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Citadel Advisors held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,710 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.

By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
  • Citadel Advisors added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
  • Citadel Advisors's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
  • Citadel Advisors fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
  • Citadel Advisors's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
  • Citadel Advisors opened 1,671 new positions and closed 1,710 in Q1 2025.
  • Citadel Advisors's portfolio value fell 8.7% quarter-over-quarter to $527B.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.